The nervous system: a new target in the fight against cancer Kazi, Rashek; Bunimovich, Yuri L. Kazi, Rashek; Bunimovich, Yuri L. Less Anti-Cancer Drugs. 29(10):929-934, November 2018. Abstract Abstract Favorites PDF Get Content & Permissions Abstract:
Apatinib reverses alectinib resistance by targeting vascular endothelial growth factor receptor 2 and attenuating the oncogenic signaling pathway in echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion gene-positive lung cancer cell lines Chen, Yanqiong; Ma, Guoliang; Su, Cuiyun; More Chen, Yanqiong; Ma, Guoliang; Su, Cuiyun; Wu, Pihua; Wang, Huilin; Song, Xiangqun; Yu, QiTao; Zeng, Aiping; Zhou, Shaozhang Less Anti-Cancer Drugs. 29(10):935-943, November 2018. Abstract Abstract Favorites PDF Get Content & Permissions Abstract: Go to Full Text of this Article
Efficacy and safety of raltitrexed-based transarterial chemoembolization for colorectal cancer liver metastases Shao, Guoliang; Liu, Ruibao; Ding, Wenbin; More Shao, Guoliang; Liu, Ruibao; Ding, Wenbin; Lu, Ligong; Li, Wentao; Cao, Huicun; Liu, Rong; Li, Caixia; Xiang, Hua; Yang, Zhengqiang; Yang, Jijin; Song, Jinlong; Wang, Jianhua Less Anti-Cancer Drugs. 29(10):1021-1025, November 2018. Abstract Abstract Favorites PDF Get Content & Permissions Abstract:
Osteoblastic bone response mimicking bone progression during treatment with pembrolizumab in advanced cutaneous melanoma Comito, Francesca; Ambrosini, Valentina; Sperandi, Francesca; More Comito, Francesca; Ambrosini, Valentina; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea Less Anti-Cancer Drugs. 29(10):1026-1029, November 2018. Abstract Abstract Favorites PDF Get Content & Permissions Abstract:
